Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 190 of 1,261
  1. US 11672793

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  2. US 11672794

    Therapeutic targeting of the BAP1 complex in cancer

    Northwestern University · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  3. US 11672811

    Materials and methods for suppressing and/or treating bone related diseases and symptoms

    The United States of America as Represented by the Department of Veteranas Affairs · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  4. US 11672801

    Compositions and methods for treating cancer

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  5. US 11674968

    Methods for identifying free thiols in proteins

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  6. US 11674177

    Kelch domain containing 7B (KLHDC7B) variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  7. US 2023174645

    ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS

    DISC MEDICINE INC [US] · Granted Jun 8, 2023 · Expires Jun 3, 2043

    granted
  8. US 11666658

    Rifamycin analogs and antibody-drug conjugates thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  9. US 11666574

    Combination therapy involving diaryl macrocyclic compounds

    TURNING POINT THERAPEUTICS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  10. US 11667687

    Masked activatable interferon constructs

    CytomX Therapeutics, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  11. US 11667683

    Articles comprising a silk polypeptide for antigen delivery

    Ludwig-Maximilians-Universitat Munchen · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  12. US 11667643

    RIP1K inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  13. US 11667637

    Fused imidazo-piperidine JAK inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  14. US 11666671

    Spatial mapping of kidney functions

    Northwestern University · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  15. US 11667611

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  16. US 11667596

    2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders

    PTC THERAPEUTICS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  17. US 11666666

    Methods and compositions for modifying a mutant dystrophin gene in a cell's genome

    The Regents of the University of California · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  18. US 11666645

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  19. US 11666634

    Methods and compositions for management of gastrointestinal disorders

    The Board of Regents of the University of Texas System · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  20. US 11666575

    Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  21. US 11666609

    Methods of treating dog urinary tract infections

    The Regents of the University of California · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  22. US 11666606

    Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases

    Prime Merger Sub, LLC · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  23. US 11666594

    Antibody-drug conjugates comprising a cyclic dinucleotide

    Takeda Pharmaceutical Company Limited · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  24. US 11666637

    Insulin-loaded metal-organic frameworks

    Northwestern University · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.